Home LiteratureArticle Details
PMID: 16585182 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract.

Cancer research ·Vol. 66 ·No. 7 ·2006-04-01 ·Pages 3576-83

Kucherlapati MH, Nguyen AA, Bronson RT, Kucherlapati RS

Abstract

We have crossed mice carrying the conditional Rb(tm2Brn) allele with a constitutive Villin-Cre transgenic mouse. The Villin promoter in these animals is highly expressed in adult intestine and kidney proximal tubules and is expressed in the gut and nephros anlagen during embryogenesis. We report here that these mice develop tumors between 12 and 17 months old outside the gastrointestinal (GI) tract. A high penetrance of pituitary tumors and medullar carcinoma of the thyroid is observed with a lower incidence of hyperplasia of pulmonary neuroendocrine cells and aggressive liver, bile duct, stomach, oral cavity tumors, and lipomas. Rb rearrangement due to ectopic Villin promoter activity in neural crest or neural crest stem cells during embryogenesis is most likely responsible for the medullar carcinoma of the thyroid phenotype. The aggressive nature of the medullar carcinoma of the thyroid and its ability to metastasize to unusual sites make the model suitable for the study of tumor progression and mechanism of metastasis. Observed sites of metastasis include the stomach, small intestine, liver, lung, kidney, pancreas, spleen, bone marrow, salivary gland, fat, lymph nodes, and dorsal root ganglion. Because the Villin promoter is highly active throughout the GI and in the nephros anlagen during development, we find that Rb inactivation is not sufficient to initiate tumorigenesis in the GI or kidneys in mice.

MeSH Terms
Alleles Animals Carcinoma, Medullary/genetics,pathology Female Gastrointestinal Neoplasms/genetics,pathology Gene Rearrangement Gene Silencing Genes, Retinoblastoma Integrases/genetics Male Mice Mice, Transgenic Microfilament Proteins/genetics Pituitary Neoplasms/genetics,pathology RNA, Neoplasm/genetics,isolation & purification Thyroid Neoplasms/genetics,pathology
Chemicals
Microfilament Proteins RNA, Neoplasm villin Cre recombinase Integrases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kucherlapati Melanie H
Harvard-Partners Center for Genetics and Genomics, Harvard Medical School, New Research Building 160B, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. mkucherlapati@rics.bwh.harvard.edu
Nguyen Andrew A
Bronson Roderick T
Kucherlapati Raju S
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2006-04-01
Pages
3576-83
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · CA 084301 · United States
NIEHS NIH HHS · ES 011040 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com